Gandhi Arpit, Wong Ka Kit, Gross Milton D, Avram Anca M
1 Nuclear Medicine/Radiology, University of Michigan , Ann Arbor, Michigan.
2 Nuclear Medicine Service , Department of Veterans Affairs Health System, Ann Arbor, Michigan.
Thyroid. 2016 Apr;26(4):573-9. doi: 10.1089/thy.2015.0396. Epub 2016 Mar 15.
Lingual thyroid is a rare abnormality of thyroid development that is usually treated conservatively with levothyroxine replacement. Rarely, it becomes large enough to cause obstructive symptoms in the oral cavity, requiring definitive treatment.
This study reports on three patients with lingual thyroid treated with radioactive iodine-131 ((131)I) with successful radioablation of their ectopic thyroid tissues. Measurement of 24-hour radioactive iodine uptake within thyroidal tissues and hybrid single-photon emission computed tomography/computed tomography imaging using either iodine-123 or technetium-99m pertechnetate scans were performed in all patients demonstrating the location and size of lingual thyroid and absence of an orthotopic thyroid gland.
The aim of this study was to describe nonsurgical management of obstructive lingual thyroid tissue with (131)I therapy for lingual thyroid radioablation. Patients were prepared with a low-iodine diet and levothyroxine withdrawal prior to radioablation for optimizing (131)I uptake in ectopic thyroid tissues. Hybrid single-photon emission computed tomography/computed tomography measurement of anatomic size of lingual thyroid tissue and radioactive iodine uptake guided the selection of therapeutic doses, resulting in administration of 10.7, 17.5, and 15.4 mCi of (131)I, respectively. There were no post-therapy complications, and clinical follow-up demonstrated resolution of obstructive oropharyngeal symptoms.
Ectopic lingual thyroid tissue is rarely associated with obstructive oropharyngeal symptoms due to progressive enlargement. Radioiodine therapy with (131)I is an effective treatment modality for ablation of ectopic thyroid tissue as an alternative to surgery.
舌甲状腺是一种罕见的甲状腺发育异常,通常采用左甲状腺素替代疗法进行保守治疗。极少情况下,它会增大到足以引起口腔梗阻症状,需要进行确定性治疗。
本研究报告了3例接受放射性碘-131(¹³¹I)治疗的舌甲状腺患者,异位甲状腺组织成功实现放射性消融。对所有患者均进行了甲状腺组织内24小时放射性碘摄取量的测量,以及使用碘-123或锝-99m高锝酸盐扫描的混合单光子发射计算机断层扫描/计算机断层扫描成像,以显示舌甲状腺的位置和大小以及是否存在正常位置的甲状腺。
本研究的目的是描述用¹³¹I治疗阻塞性舌甲状腺组织以实现舌甲状腺放射性消融的非手术管理方法。在放射性消融前,患者采用低碘饮食并停用左甲状腺素,以优化¹³¹I在异位甲状腺组织中的摄取。通过混合单光子发射计算机断层扫描/计算机断层扫描测量舌甲状腺组织的解剖大小和放射性碘摄取量来指导治疗剂量的选择,结果分别给予10.7、17.5和15.4毫居里的¹³¹I。治疗后无并发症,临床随访显示口咽梗阻症状得到缓解。
异位舌甲状腺组织很少因逐渐增大而导致口咽梗阻症状。¹³¹I放射性碘治疗是消融异位甲状腺组织的一种有效治疗方式,可作为手术的替代方法。